Vancouver, B.C. – Acuitas Therapeutics recently announced the publication of a new study inMolecular Therapy – Nucleic Acids, titled “mRNA-LNP vaccine encoding the Plasmodium vivax circumsporozoite protein is highly immunogenic… Read More
Dementia is a growing public health concern, affecting more than 55 million people worldwide, according to the World Health Organization.1 With nearly 10 million new cases diagnosed each year, the need… Read More
Proprietary yeast-based technology platform for producing and delivering RNA with applications in multiple large-scale global industries Canada, YVR — Renaissance BioScience Corp. is pleased to announce that it has been… Read More
Patients share experiences of confusion, fear and fragmented care in managing pregnancies at risk for hemolytic disease of the fetus and newborn (HDFN) or fetal neonatal alloimmune thrombocytopenia (FNAIT) under… Read More
NORTH CHICAGO, Ill. – AbbVie announced updated results from the Phase 2 EPCORE® NHL-6 trial (NCT05451810) evaluating the feasibility of dosing and monitoring patients in the outpatient setting for the first… Read More
